BioAge Labs (BIOA) Share-based Compensation (2023 - 2026)

BioAge Labs has disclosed Share-based Compensation across 4 years of filings, most recently posting $9.2 million for Q2 2026.

• In Q2 2026, Share-based Compensation rose 13.74% year-over-year to $9.2 million; the TTM figure through Jun 2026 stood at $9.2 million (up 13.74% YoY), while the FY2025 annual figure was $23.8 million, down 9.85% from the prior year.
• Share-based Compensation came in at $9.2 million for Q2 2026 at BioAge Labs, down from $9.3 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $9.3 million in Q1 2026 to a low of $757000.0 in Q3 2023.
• Average Share-based Compensation over 4 years is $4.8 million, with a median of $4.0 million recorded in 2024.
• The largest YoY upside for Share-based Compensation was 836.0% in 2025 against a maximum downside of 0.04% in 2025.
• Over 4 years, Share-based Compensation stood at $767000.0 in 2023, then soared by 254.76% to $2.7 million in 2024, then advanced by 0.04% to $2.7 million in 2025, then jumped by 236.29% to $9.2 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $9.2 million in Q2 2026, $9.3 million in Q1 2026, and $2.7 million in Q4 2025.